2002 Press Releases in PDF Format

January 2
CONTROL OF FAT CELL DEVELOPMENT DEMONSTRATED
USING SANGAMO BIOSCIENCES’ ZFP TECHNOLOGY
In vivo studies on function of gene variant critical to development of fat cells conducted in collaboration with Pfizer scientists

January 9
SANGAMO BIOSCIENCES AND MEDAREX, INC. ANNOUNCE ANTIBODY
PRODUCTION AGREEMENT

January 15
SANGAMO BIOSCIENCES ANNOUNCES AGREEMENT WITH WYETH-AYERST LABORATORIES

January 29
SANGAMO BIOSCIENCES ANNOUNCES FOURTH QUARTER 2001 TELECONFERENCE

February 5
SANGAMO BIOSCIENCES REPORTS 2001 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS

February 25
SANGAMO BIOSCIENCES ANNOUNCES PRESENTATION AT LEHMAN BROTHERS HEALTHCARE CONFERENCE

March 5
SANGAMO BIOSCIENCES GRANTED U.K. PATENT COVERING DESIGN AND SYNTHESIS OF ZINC FINGER DNA-BINDING PROTEINS

March 19
SANGAMO BIOSCIENCES ANNOUNCES FOUR SCIENTIFIC PUBLICATIONS BY COMPANY SCIENTISTS

April 18
SANGAMO BIOSCIENCES ANNOUNCES FIRST-QUARTER 2002 TELECONFERENCE

April 25
SANGAMO BIOSCIENCES REPORTS FIRST-QUARTER FINANCIAL RESULTS

June 3
SANGAMO BIOSCIENCES ANNOUNCES PRESENTATION AT THE NEEDHAM AND COMPANY FIRST ANNUAL BIOTECHNOLOGYCONFERENCE

June 4
SANGAMO BIOSCIENCES PRESENTS SCIENTIFIC ADVANCES AT THE 2002 ANNUAL MEETING OF THE AMERICAN SOCIETY OF GENE THERAPY

June 6
SANGAMO BIOSCIENCES PRESENTS PROGRESS ON THERAPEUTIC CANCER VACCINE AT AMERICAN SOCIETY OF GENE THERAPY MEETING

June 6
SANGAMO BIOSCIENCES PRESENTS PROGRESS ON COMPANY’S LEAD ZFP TF THERAPEUTIC AT AMERICAN SOCIETY OF GENE THERAPY MEETING

June 7
SANGAMO BIOSCIENCES PRESENTS DATA ON INDUCIBLE REGULATION OF AN ENDOGENOUS GENE USING A “SWITCHABLE” ENGINEERED TRANSCRIPTION FACTOR

June 10
SANGAMO BIOSCIENCES ANNOUNCES PRESENTATION AT THE BIO 2002 INTERNATIONAL BIOTECHNOLOGY CONVENTION AND EXHIBITION

June 24
SANGAMO BIOSCIENCES ANNOUNCES PRESENTATION AT THE WILLIAM BLAIR & COMPANY 22ND ANNUAL GROWTH STOCK CONFERENCE

July 16
SANGAMO BIOSCIENCES ANNOUNCES SMALL MOLECULE SCREENING COLLABORATION WITH ICAGEN

July 17
SANGAMO BIOSCIENCES ANNOUNCES SECOND-QUARTER 2002 TELECONFERENCE

July 23
SANGAMO BIOSCIENCES ANNOUNCES FEDERAL GRANT TO APPLY ZFP TECHNOLOGY TO TREATMENT OF SICKLE CELL DISEASE

July 24
SANGAMO BIOSCIENCES REPORTS SECOND-QUARTER FINANCIAL RESULTS

September 17
SANGAMO BIOSCIENCES GRANTED U.S. PATENT COVERING METHODS FOR ENGINEERING ZINC FINGER DNA-BINDING PROTEINS AND SELECTING PREFERRED DNA BINDING SITES

September 19
SANGAMO BIOSCIENCES PRESENTS SMALL MOLECULE DRUG DISCOVERY PLATFORM AT THE 8TH ANNUAL CONFERENCE OF THE SOCIETY FOR BIOMOLECULAR SCREENING

September 23
SANGAMO BIOSCIENCES PRESENTS NOVEL APPROACH TO SMALL MOLECULE DRUG DISCOVERY AT SOCIETY FOR BIOMOLECULAR SCREENING MEETING
The use of Zinc Finger DNA Binding Protein Transcription Factors to avoid cdna Patents

September 25
SANGAMO BIOSCIENCES TO PRESENT NOVEL SCREENING SYSTEM FOR DRUGS THAT AFFECT SIGNALING PATHWAYS AT SOCIETY FOR BIOMOLECULAR SCREENING ANNUAL CONFERENCE

October 1
SANGAMO BIOSCIENCES AND AVIGEN ANNOUNCE RESEARCH COLLABORATION FOR THE TREATMENT OF CHRONIC PAIN

October 22
SANGAMO BIOSCIENCES ANNOUNCES THE APPOINTMENT OF JANET L. NIBEL
AS VICE PRESIDENT OF FINANCE AND ADMINSTRATION

October 23
SANGAMO BIOSCIENCES ANNOUNCES THIRD-QUARTER 2002 TELECONFERENCE

October 28
SANGAMO BIOSCIENCES RECEIVES PHASE II SBIR GRANT EXPANDING THERAPEUTIC PRODUCT PLATFORM

October 30
SANGAMO BIOSCIENCES REPORTS THIRD-QUARTER FINANCIAL RESULTS

November 4
SANGAMO BIOSCIENCES ANNOUNCES PUBLICATION IN NATURE MEDICINE
OF FIRST IN VIVO DATA FROM LEAD THERAPEUTIC PROGRAM
Study with Yale University describes potential benefit of using Sangamo’s engineered ZFP transcription factors in coronary artery and peripheral arterial disease therapies

November 11
SANGAMO BIOSCIENCES ANNOUNCES PRESENTATION AT THE
WALL STREET ANALYST FORUM

November 19
SANGAMO BIOSCIENCES ANNOUNCES THE EXTENSION AND EXPANSION
OF ZFP THERAPEUTIC PRODUCT DEVELOPMENT PROGRAMS
Edwards Lifesciences Commits $2.95 million in New Research and Development Funding to Sangamo